Dissimilarly, in RA synovial/SCID mouse chimera model, a selective D1-like receptor antagonist SCH-23390 alleviates both accumulation of IL-6+ and IL-17+ T cells and cartilage destruction [47], suggesting an involvement of D1-like receptors in RA disease. Here, IL17A is linked to rheumatoid arthritis.